Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124032122 | 12403212 | 2 | F | 20160401 | 20160627 | 20160525 | 20160705 | EXP | FR-ELI_LILLY_AND_COMPANY-FR201605004661 | ELI LILLY AND CO | 73.05 | YR | F | Y | 0.00000 | 20160705 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124032122 | 12403212 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 30 MG, DAILY | 21427 | 30 | MG | CAPSULE | QD | ||||||
| 124032122 | 12403212 | 2 | SS | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 2 DF THREE TIMES DAILY | Y | U | 0 | 2 | DF | TID | |||||
| 124032122 | 12403212 | 3 | SS | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 1 G, BID | Y | U | 0 | 1 | G | BID | |||||
| 124032122 | 12403212 | 4 | SS | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 124032122 | 12403212 | 5 | SS | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Oral | 1 DF THREE TIMES A DAY | 0 | 1 | DF | TID | |||||||
| 124032122 | 12403212 | 6 | SS | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 30 MG, TWICE DAILY | 0 | 30 | MG | BID | |||||||
| 124032122 | 12403212 | 7 | SS | ALPRAZOLAM MERCK | ALPRAZOLAM | 1 | Oral | 1 DF THREE TIMES DAILY | 0 | 1 | DF | TABLET | TID | ||||||
| 124032122 | 12403212 | 8 | C | DOLIPRANE | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 124032122 | 12403212 | 9 | C | INNOHEP | TINZAPARIN SODIUM | 1 | 0 | ||||||||||||
| 124032122 | 12403212 | 10 | C | PYOSTACINE | PRISTINAMYCIN | 1 | 0 | ||||||||||||
| 124032122 | 12403212 | 11 | C | LACRIFLUID | CARBOMER | 1 | 0 | ||||||||||||
| 124032122 | 12403212 | 12 | C | TAMOXIFENE | TAMOXIFEN | 1 | 0 | ||||||||||||
| 124032122 | 12403212 | 13 | C | NORDAZ | NORDAZEPAM | 1 | Y | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124032122 | 12403212 | 1 | Anxiety |
| 124032122 | 12403212 | 2 | Herpes zoster |
| 124032122 | 12403212 | 4 | Anxiety |
| 124032122 | 12403212 | 6 | Pain |
| 124032122 | 12403212 | 7 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124032122 | 12403212 | HO |
| 124032122 | 12403212 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124032122 | 12403212 | Confusional state | |
| 124032122 | 12403212 | Hallucination | |
| 124032122 | 12403212 | Herpes zoster |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124032122 | 12403212 | 2 | 20160401 | 20160407 | 0 | |
| 124032122 | 12403212 | 3 | 20160408 | 20160408 | 0 | |
| 124032122 | 12403212 | 5 | 20160405 | 0 | ||
| 124032122 | 12403212 | 7 | 20160402 | 0 |